190 related articles for article (PubMed ID: 28715344)
1. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.
Othman F; Crooks CJ; Card TR
BMJ; 2016 Nov; 355():i5813. PubMed ID: 28715344
[No Abstract] [Full Text] [Related]
2. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
3. Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.
Zirk-Sadowski J; Masoli JA; Delgado J; Hamilton W; Strain WD; Henley W; Melzer D; Ble A
J Am Geriatr Soc; 2018 Jul; 66(7):1332-1338. PubMed ID: 29676433
[TBL] [Abstract][Full Text] [Related]
4. Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population.
Cohen SM; Lee HJ; Leiman DA; Roy N; Misono S
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):519-525. PubMed ID: 30419774
[TBL] [Abstract][Full Text] [Related]
5. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia.
Jena AB; Sun E; Goldman DP
J Gen Intern Med; 2013 Feb; 28(2):223-30. PubMed ID: 22956446
[TBL] [Abstract][Full Text] [Related]
6. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
[TBL] [Abstract][Full Text] [Related]
7. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
[TBL] [Abstract][Full Text] [Related]
8. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
Xun X; Yin Q; Fu Y; He X; Dong Z
Ann Pharmacother; 2022 May; 56(5):524-532. PubMed ID: 34425689
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.
Filion KB; Chateau D; Targownik LE; Gershon A; Durand M; Tamim H; Teare GF; Ravani P; Ernst P; Dormuth CR;
Gut; 2014 Apr; 63(4):552-8. PubMed ID: 23856153
[TBL] [Abstract][Full Text] [Related]
11. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
[TBL] [Abstract][Full Text] [Related]
12. Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.
de Groot MC; Klungel OH; Leufkens HG; van Dijk L; Grobbee DE; van de Garde EM
Eur J Epidemiol; 2014 Oct; 29(10):767-75. PubMed ID: 25154551
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
14. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
15. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
Sarkar M; Hennessy S; Yang YX
Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitors and Infant Pneumonia/Other Lower Respiratory Tract Infections: National Nested Case-control Study.
Blank ML; Parkin L; Zeng J; Barson D
J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):335-340. PubMed ID: 29601438
[TBL] [Abstract][Full Text] [Related]
18. Acid-suppressive drugs and community-acquired pneumonia.
Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
[TBL] [Abstract][Full Text] [Related]
19. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
20. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
Linton A; Bacon T; Peterson M
J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
